BioSpace News Archive

hildren’s National Health System has acquired the latest virtual reality surgical system from Surgical Theater, a leading provider of the FDA-approved breakthrough technology for healthcare

The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets - lot number MON17384, expiration 12/31/2019

First responders to major chemical exposure incidents in the United States can improve treatment protocols for at-risk casualties with better communication strategies, according to new analysis in Annals of Emergency Medicine.

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, 2.5 mg/0.025 mg. Upsher-Smith’s product is an AA-rated generic version of the branded product, Lomotil® (diphenoxylate hydrochloride and atropine sulfate tablets)*.

The Teamsters, as part of a multi-union coalition, has reached a tentative agreement on the national addendum with American Red Cross.

Regional Health Properties, Inc. today announced that, on August 28, 2018, that the Company received a deficiency letter (the “Letter”) from NYSE American LLC

PolarityTE (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today announced it will report its fiscal third quarter 2018 financial results by press release on September 12, 2018 at approximately 7:30am Eastern Time.

Amneal Pharmaceuticals (NYSE: AMRX) today announced that it plans to participate at the following upcoming investor conferences. Wells Fargo 2018 Healthcare Conference at 9:10 a.m. ET on September 6, 2018 in Boston, MA. Morgan Stanley 16th Annual Global Healthcare Conference at 11:05 a.m. ET on September 12, 2018 in New York, NY.

ViewRay Incorporated (NASDAQ: VRAY) announced today that members of the executive management team are scheduled to participate in two upcoming investor conferences.

Technavio analysts forecast the global deep brain stimulation devices market to grow at a CAGR of over 12% during the forecast period, according to their latest market research report.